A Biomimetic Dual‐Targeting Nano‐APA‐Editor Reprograms the 3'UTR Landscape for Tongue Squamous Cell Carcinoma Therapy
Advanced Science · 2026
DOI: 10.1002/advs.76126 ↗At a glance
Journal article in Advanced Science, 2026. Written by Yiran Ao and 5 co-authors. Institution: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Hubei Key Laboratory of Stomatology, Key Laboratory of Oral Biomedicine…. Major MEDLINE topics: 3' Untranslated Regions, Biomimetics, Tongue Neoplasms, Cleavage And Polyadenylation Specificity Factor. 61 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (original language)
Targeting post‐transcriptional dysregulation of tumor suppressors represents a new frontier in cancer therapy. Here, we identify the alternative polyadenylation (APA) regulator NUDT21 as a pivotal therapeutic target in oral squamous cell carcinoma (OSCC). NUDT21 is highly upregulated, correlating strongly with poor survival and advanced clinical stage. We outline a pathogenic mechanism whereby NUDT21 drives this phenotype by forcing a network of tumor suppressor transcripts, notably PTEN, into translationally‐repressed, long‐3'UTR isoforms. To therapeutically “re‐engineer” this APA switch, we design a “Nano‐APA‐editor.” This platform features an HMSN core with an sgRNA‐NUDT21 payload and a hierarchical targeting strategy: a cancer‐educated dendritic cell (DC) membrane for biomimetic camouflage and homotypic affinity, “gated” by a TA‐aptamer for final precision. This system enables potent and selective NUDT21 silencing, driving a shift toward short‐3'UTR isoforms. Consequently, the Nano‐APA‐editor effectively reinstates PTEN and associated suppressors and inhibits multiple malignant phenotypes in vitro. In an orthotopic OSCC model, it demonstrates profound tumor regression, outperforming conventional chemotherapy (PTX) with excellent biocompatibility. In vivo analysis confirmed target engagement (NUDT21‐down) and functional restoration (PTEN‐, WEE1‐, TGF‐β‐up). This work validates a “post‐transcriptional re‐engineering” strategy, executed by a logically designed nanoplatform, as a powerful and safe modality for precision gene therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Hubei Key Laboratory of Stomatology, Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan Univer…
- Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, P. R. China.
ORCID profiles: Qin Zhao
Funding
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Cite
APA
Ao, Y., Gu, B., Zhao, H., Tan, K., Zhao, Q., & Shang, Z. (2026). A Biomimetic Dual‐Targeting Nano‐APA‐Editor Reprograms the 3'UTR Landscape for Tongue Squamous Cell Carcinoma Therapy. Advanced Science. https://doi.org/10.1002/advs.76126
Vancouver
Ao Y, Gu B, Zhao H, Tan K, Zhao Q, Shang Z. A Biomimetic Dual‐Targeting Nano‐APA‐Editor Reprograms the 3'UTR Landscape for Tongue Squamous Cell Carcinoma Therapy. Advanced Science. 2026. doi:10.1002/advs.76126
BibTeX
@article{Ao2026,
author = {Ao, Yiran and Gu, Bin and Zhao, Hui and Tan, Kun and Zhao, Qin and Shang, Zhengjun},
title = {A Biomimetic Dual‐Targeting Nano‐APA‐Editor Reprograms the 3'UTR Landscape for Tongue Squamous Cell Carcinoma Therapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76126}
}
EUVIMED